Cargando…

Pharmacotherapy of the Lipid-Lowering Drugs: Update on Efficacy and Risk

Detalles Bibliográficos
Autores principales:	Pierno, Sabata, Musumeci, Olimpia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9864443/ https://www.ncbi.nlm.nih.gov/pubmed/36674512 http://dx.doi.org/10.3390/ijms24020996

Ejemplares similares

Statin-Induced Myopathy: Translational Studies from Preclinical to Clinical Evidence
por: Camerino, Giulia Maria, et al.
Publicado: (2021)

Quest for pharmacotherapy in aortic valve stenosis: the lipid hypothesis
por: Zheng, Kang H, et al.
Publicado: (2020)

Lipid-lowering pharmacotherapy and socioeconomic status: atherosclerosis risk in communities (ARIC) surveillance study
por: Kitzmiller, Joseph P, et al.
Publicado: (2013)

Metabolic Pathways and Ion Channels Involved in Skeletal Muscle Atrophy: A Starting Point for Potential Therapeutic Strategies
por: Canfora, Ileana, et al.
Publicado: (2022)

Risk of Myopathy in Patients in Therapy with Statins: Identification of Biological Markers in a Pilot Study
por: Camerino, Giulia M., et al.
Publicado: (2017)

Pharmacotherapy of obesity: an update on the available medications and drugs under investigation
por: Chakhtoura, Marlene, et al.
Publicado: (2023)

Update on Pharmacotherapy in Psychodermatological Disorders
por: Shenoi, Shrutakirthi D., et al.
Publicado: (2020)

The examination of geriatric pharmacotherapy
por: Farinde, Abimbola
Publicado: (2013)

Non-Compliance in Pharmacotherapy
por: Reddy, M. S.
Publicado: (2012)

Taurine: the appeal of a safe amino acid for skeletal muscle disorders
por: De Luca, Annamaria, et al.
Publicado: (2015)

Early is better? A new algorithm for early diagnosis in Late Onset Pompe Disease (LOPD)
por: TOSCANO, ANTONIO, et al.
Publicado: (2013)

Potential pharmacotherapy for Zinner syndrome
por: Takeshima, Teppei
Publicado: (2023)

Pharmacotherapy of pediatric metabolic syndrome
por: Kelishadi, Roya, et al.
Publicado: (2013)

Obesity Treatment – Is Pharmacotherapy the Answer?
por: Rangbulla, Aditya Kumar
Publicado: (2020)

Therapeutic Targets in Amyotrophic Lateral Sclerosis: Focus on Ion Channels and Skeletal Muscle
por: Tarantino, Nancy, et al.
Publicado: (2022)

Update on pharmacotherapies for cholestatic liver disease
por: Ali, Ahmad H., et al.
Publicado: (2016)

Lipid-lowering and kidney
por: Lee, Sang-Hak
Publicado: (2023)

Pharmacotherapy for Age-Related Macular Degeneration
por: Ahmadieh, Hamid
Publicado: (2008)

Pharmacotherapy during Pregnancy, Childbirth, and Lactation
por: Allegaert, Karel
Publicado: (2022)

Orexin Receptor Competitive Antagonists: A Novel target of the Sedative and hypnotics drugs for the pharmacotherapy of Insomnia
por: Banerjee, Indrajit
Publicado: (2018)

Editorial for the Special Issue “New Strategies in Cancer Pharmacotherapy: Development of Hormonal Antineoplastic Drugs, Cytotoxic Drugs and Targeted Therapies”
por: Martínez-Campa, Carlos, et al.
Publicado: (2020)

Update on the pharmacotherapy of cerebellar and central vestibular disorders
por: Kalla, Roger, et al.
Publicado: (2016)

Update on pharmacotherapy for ocular surface squamous neoplasia
por: Al Bayyat, Ghada, et al.
Publicado: (2019)

Anti-Diabetogenic Properties of Mineralocorticoid Receptor Antagonists: Implications for Enhanced Safety and Efficacy of Post-Transplantation Pharmacotherapies
por: Ming, Yingzi, et al.
Publicado: (2019)

Drug Efficacy Monitoring in Pharmacotherapy of Multiple Sclerosis With Biological Agents
por: Caldano, Marzia, et al.
Publicado: (2017)

Update on Lower Urinary Tract Symptoms
por: Badlani, Gopal H.
Publicado: (2009)

Are we over-dependent on pharmacotherapy?
por: Kallivayalil, Roy Abraham
Publicado: (2008)

Pharmacotherapy for Gastroparesis: An Attempt to Evaluate a Safer Alternative
por: Ghoshal, Uday C
Publicado: (2010)

Pharmacotherapy for Adult Patients with Acute Respiratory Distress Syndrome
por: Yin, Jun, et al.
Publicado: (2018)

A New Landscape for Systemic Pharmacotherapy of Recurrent Glioblastoma?
por: Lombardi, Giuseppe, et al.
Publicado: (2020)

Nanoengineered on-demand drug delivery system improves efficacy of pharmacotherapy for epilepsy
por: Wu, Di, et al.
Publicado: (2022)

Trials and Treatments: An Update on Pharmacotherapy for Idiopathic Pulmonary Fibrosis
por: Thong, Lorraine, et al.
Publicado: (2023)

Pharmacotherapies of NAFLD: updated opportunities based on metabolic intervention
por: Shao, Yaodi, et al.
Publicado: (2023)

Kidney Drug Transporters in Pharmacotherapy
por: Łapczuk-Romańska, Joanna, et al.
Publicado: (2023)

Updates in pharmacotherapy of heart failure with reduced ejection fraction
por: Espinoza, Clifton, et al.
Publicado: (2021)

Editorial: New Trends and Approaches in Perioperative Pharmacotherapy: An Update
por: Soghomonyan, S., et al.
Publicado: (2021)

Pharmacotherapy of Painful Diabetic Neuropathy: A Clinical Update
por: James, Cornelius Fernandez, et al.
Publicado: (2022)

Methods to Attain Optimal Outcomes With Lipid-Lowering Drug Therapy
por: Curtiss, Frederic R.
Publicado: (2004)

Use of Lipid-, Blood Pressure–, and Glucose-Lowering Pharmacotherapy in Patients With Type 2 Diabetes and Atherosclerotic Cardiovascular Disease
por: Nelson, Adam J., et al.
Publicado: (2022)

Antithrombotic therapy in patients with COVID-19: indications, pharmacotherapy and controversy
por: Wang, David, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1ig8o9hld00mtilst5spo0hr5q